NOVO NORDISK RETATRUTIDE VS. DUROLANE : A THOROUGH EXAMINATION

Considering both Novera Retatrutide and Hyalgan Durolane target joint pain , their methods of effect are distinctly contrasting. Novo Nordisk's Retatrutide is a dual agonist affecting glucagon-like peptide-1 and the GIP receptor, primarily used for weight control , which potentially